glp-1 and pancreatic cancer The effect of GLP-1R agonists on the medical triad of obesity, diabetes, | Cancer and Metastasis Reviews Do GLP-1–Based Therapies Increase Cancer

Lancet 330, 13001304

This powerful protein can override physical feelings of fullness, like pressure in your stomach, so your brain thinks you need more food when you really dont

At research-level dosages, studies have not reported extensive adverse effects

Among Medicare patients, 18% started with a GLP-1 while 24% used an SGLT2, reflecting the higher prevalence of cardiovascular conditions in seniors and the dual benefits SGLT2s provide in heart health

Metabolic syndrome is a cluster of conditions-increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels-that occur together, increasing your risk of heart disease, stroke, and type 2 diabetes

I think that will lead to better adherence than [semaglutide] pills, which you have to take every day on an empty stomach and then wait 30 minutes to eat